Symptomatic hiatal hernia (HH) with pouch migration is a rare complication after laparoscopic Roux-en-Y gastric bypass (RYGB), and there is limited evidence on the utility of surgical repair. In this retrospective review of 44 patients who underwent isolated HH repair after previous RYGB, researchers found that common symptoms were dysphagia and reflux. Surgical repair resulted […]
Category: Metabolic and Bariatric Surgery
Intensive Dietary Support Leads to Greater Weight Loss in Asian Bariatric Patients
Intensive dietary support significantly boosts weight loss and BMI reduction in an Asian population undergoing bariatric surgery, as demonstrated by a retrospective study. The group receiving intensive dietary support had notably superior outcomes at 6 and 12 months compared to those following standard care, without a significant difference in postoperative complications. Journal Article by Sim […]
GERD After OAGB: 2% Incidence, 100% Success in Surgical Treatments
The systematic review and meta-analysis investigated gastroesophageal reflux disease (GERD) as a major concern following one anastomosis gastric bypass (OAGB). The analysis of 40 studies involving 17,299 patients revealed that 2% of patients experienced GERD after OAGB, with reflux rates six times higher in revisional OAGB compared to primary OAGB. Medical and surgical treatments were […]
One Anastomosis Gastric Bypass Yields Better Long-Term Outcomes Than Roux-en-Y Gastric Bypass and Sleeve Gastrectomy
Patients who underwent one Anastomosis Gastric Bypass (OAGB) had significantly higher total BAROS scores at the five-year follow-up compared to those who underwent Roux-en-Y Gastric Bypass (RYGB) and Sleeve Gastrectomy (SG). All three common metabolic and bariatric surgical procedures (SG, RYGB, and OAGB) significantly improved the quality of life after surgery. This retrospective study of […]
Metabolic surgery leads to weight loss, improved comorbid conditions, lower incidence of cardiovascular events, cancer, and death, but also carries risks.
Metabolic/bariatric surgery is an effective and durable treatment for obesity, resulting in significant weight loss and improvements in comorbid conditions, including type 2 diabetes. It is associated with a lower incidence of cardiovascular events, cancer, and death. However, there is a risk of weight regain and an increased risk of developing substance and alcohol use […]
Higher Weight Loss and Postprandial Regurgitation in Banded Sleeve Gastrectomy
Five-year results from a three-year randomized controlled trial comparing banded and non-banded sleeve gastrectomy (SG) showed that banded sleeve gastrectomy (BSG) resulted in significantly higher excess weight loss (9%) and total weight loss (4.2%) compared to non-banded SG. Most patients experienced remission of type 2 diabetes, with no significant difference between the two groups. However, […]
Association Between COVID-19 Diagnosis and Postoperative Outcomes in Bariatric Surgery Patients
Patients with a postoperative diagnosis of COVID-19 after bariatric surgery had worse outcomes, including a higher risk of anastomotic/staple line leak, postoperative pneumonia, and 30-day reoperation. However, patients who had COVID-19 before surgery had similar outcomes to those without COVID-19. The study suggests that it is safe to perform bariatric surgery on patients recently recovered […]
SF-BARI Score as a Standard Tool for Metabolic Bariatric Surgery Outcomes
Researchers analyzed data from two randomized clinical trials to assess the feasibility of using the Swiss-Finnish Bariatric Metabolic Outcome Score (SF-BARI score) as a standardized tool for measuring outcomes in metabolic bariatric surgery (MBS). They found that the SF-BARI score, which includes measures of weight loss, comorbidities, complications, and quality of life, was correlated with […]
High Incidence of Pancreatic Exocrine Insufficiency After Non-Pancreatic Upper Gastrointestinal Surgery: Implications for Enzyme Replacement Therapy
Approximately 36% of patients who undergo non-pancreatic upper gastrointestinal surgeries develop pancreatic exocrine insufficiency (PEI), which can have detrimental effects on their health. The incidence of PEI was found to be 23% after bariatric metabolic surgery and 50.4% after oesophagogastric resection, with even higher rates after certain procedures. Diagnostic testing using fecal elastase 1 was […]
International Consensus Guides Obesity Management: IFSO Delphi Study
In a Delphi survey involving 43 global obesity experts, unanimous consensus (≥70% agreement) was achieved on 15 essential definitions and reporting standards in metabolic bariatric surgery (MBS). Notable agreement (95/121 statements) covered preferred surgical procedures like Roux-en-Y gastric bypass and sleeve gastrectomy. Moderate consensus existed for specific procedures, but none for intra-gastric balloons. Agreement extended […]